Skip to main content

News

By Jessica Hagen | 04:09 pm | January 03, 2024
The lawsuit, filed on behalf of purchasers of Veradigm's common stock, alleges the company and its executives overstated the business's historical revenues by at least $20 million.
By Jessica Hagen | 05:52 pm | January 02, 2024
The funds come two years after the company scored a $1.15 billion investment.
By Jessica Hagen | 02:13 pm | January 02, 2024
The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.
By Jessica Hagen | 05:35 pm | December 29, 2023
Digital health leaders say frameworks already exist that can be adopted for AI regulation, but going too far with rules could stifle innovation.
By Adam Ang | 11:48 pm | December 28, 2023
Also, researchers from India have developed an AI model that can detect indications of carpal tunnel syndrome in ultrasound videos. 
By Jessica Hagen | 04:06 pm | December 28, 2023
The U.S. Court of Appeals for the Federal Circuit has temporarily stopped an import ban issued by the International Trade Commission prohibiting the sale of Apple Watch Series 9 and Watch Ultra 2 in the U.S.
By Jessica Hagen | 02:01 pm | December 28, 2023
The company offers diagnostic tests and therapeutics to detect and treat endometriosis, female fertility and bacterial vaginosis.
By Jessica Hagen | 05:24 pm | December 27, 2023
From the end of the Public Health Emergency to the launch of ChatGPT and the Apple Vision Pro, executives reflect on what stood out to them this year.
By Jessica Hagen | 01:57 pm | December 27, 2023
President Biden failed to overturn a U.S. International Trade Commission ban on sales and imports of Watch Series 9 and Watch Ultra 2.
By Jessica Hagen | 10:39 pm | December 26, 2023
Employers aligned with Carrum can offer two years of treatment coverage to non-metastatic breast cancer patients via Florida Cancer Specialists & Research Institute.